Replies to post #173454 on Biotech Values

[DewDiligence]

TMO’s 2014 guidance:

http://finance.yahoo.com/news/thermo-fisher-scientific-reports-fourth-110000259.html

The company expects to achieve adjusted i.e. non-GAAP] EPS in the range of $6.70 to $6.90 for 2014, which would result in 24% to 27% adjusted EPS growth over 2013. The company expects to achieve 2014 revenue in the range of $16.63 billion to $16.83 billion, for 27% to 29% revenue growth year over year.

These numbers are boosted by the acquisition of LIFE, which is expected to close soon.